Skip to main content
Medic Debate
- The Antidote to Medical Misinformation and Propaganda!
Languages
Dansk
Nederlands
English
Français
Deutsch
Italiano
Español
Kiswahili
Svenska
Search form
Search
Main menu
Home
Search
About us
Books
Category Search
Log In
Recent posts
Treatment Protocols
You are here
Home
Malignant Melanoma
Items per page
5
10
20
40
60
100
Title
Average Rating
Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomide.
50.00%
A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone mela
90.00%
Artesunate in the treatment of metastatic uveal melanoma--first experiences.
90.00%
63 year old woman with stage III malignant melanoma
100.00%
A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin....
50.00%
Adjuvant vaccination with melanoma antigen pulsed dendritic cells (DCs) in stage III melanoma patients.
85.00%
Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
80.00%
Artemisinin derivates in the treatment of Cancer
90.00%
Bio-Immune therapy according to Professor Thomas Tallberg, a cure for Melanoma?
97.50%
Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells
80.00%
Combining agents that target the tumor microenvironment improves the efficacy of anticancer therapy.
90.00%
Correlation between prior therapeutic dendritic cell vaccination and the outcome of patients with metastatic melanoma treated...
30.00%
Dendritic Cell Therapy
30.00%
Dendritic cell vaccination in melanoma patients: Update and subgroup analysis of clinical response to post-vaccine treatment.
80.00%
Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in
80.00%
Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a
90.00%
Does chemosensitivity-assay-directed therapy have an influence on the prognosis of patients with malignant melanoma stage IV? ..
90.00%
Effect of indomethacin plus ranitidine in advanced melanoma patients on high-dose interleukin-2.
80.00%
Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regi
80.00%
Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells.
70.00%
Improvement of the recurrence-free interval using biological adjuvant therapy in uveal melanoma.
100.00%
Inhibition of angiogenesis by non-toxic doses of temozolomide.
50.00%
Metronomic schedule of temozolomide with conventional dose of cisplatin in metastatic melanoma. Sub-category: Melanoma Categor
90.00%
Multicenter phase II study of temozolomide therapy for brain metastasis in patients with malignant melanoma, breast cancer......
60.00%
Optimizing a novel regional chemotherapeutic agent against melanoma: hyperthermia-induced enhancement of temozolomide cytot.....
80.00%
Oral metronomic cyclophosphamide in elderly with metastatic melanoma.
70.00%
Primary melanocytic tumor of the cerebellopontine angle mimicking a vestibular schwannoma: case report.
60.00%
Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study.
90.00%
Systems biology: a therapeutic target for tumor therapy.
86.67%
Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Onco
40.00%
The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhib
Therapeutic vaccination with an autologous TriMix-Dendritic cell vaccine combined with sequential interferon alfa-2b in ........
90.00%
Ukrain monotherapy in malignant melanoma (case report)
80.00%
Ukrain with chemotherapy in malignant melanoma (case report)
50.00%